Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 4
2011 6
2014 2
2015 3
2016 3
2017 4
2018 5
2019 15
2020 16
2021 11
2022 7
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I; innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators. Coleman RL, et al. Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845034 Clinical Trial.
Low-grade serous ovarian cancer: State of the science.
Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O'Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fernández ML, Ray-Coquard I, Gershenson DM. Slomovitz B, et al. Among authors: schlumbrecht m. Gynecol Oncol. 2020 Mar;156(3):715-725. doi: 10.1016/j.ygyno.2019.12.033. Epub 2020 Jan 20. Gynecol Oncol. 2020. PMID: 31969252 Review.
Wilms Tumor of the Uterus.
Pinto A, Huang M, Castillo RP, Schlumbrecht MP. Pinto A, et al. Among authors: schlumbrecht mp. Int J Gynecol Pathol. 2019 Jul;38(4):335-339. doi: 10.1097/PGP.0000000000000500. Int J Gynecol Pathol. 2019. PMID: 29629978 Review.
Gynecologic oncology fellowship leadership trends by gender.
Rodriguez Yanes N, Vilariño V, Rodriguez GF, Rosete OJ, Zippi Z, Schachner B, Schlumbrecht MP. Rodriguez Yanes N, et al. Among authors: schlumbrecht mp. Gynecol Oncol Rep. 2023 Aug 12;49:101256. doi: 10.1016/j.gore.2023.101256. eCollection 2023 Oct. Gynecol Oncol Rep. 2023. PMID: 37636494 Free PMC article. Review.
Normal Risk Ovarian Screening Study: 21-Year Update.
Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC Jr. Han CY, et al. Among authors: schlumbrecht m. J Clin Oncol. 2024 Apr 1;42(10):1102-1109. doi: 10.1200/JCO.23.00141. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194613
Polypharmacy in Patients with Ovarian Cancer.
Oldak S, Ioannou S, Kamath P, Huang M, George S, Slomovitz B, Schlumbrecht M. Oldak S, et al. Among authors: schlumbrecht m. Oncologist. 2019 Sep;24(9):1201-1208. doi: 10.1634/theoncologist.2018-0807. Epub 2019 Apr 5. Oncologist. 2019. PMID: 30952819 Free PMC article.
Survival for endometrial cancer as a second primary malignancy.
Medina HN, Schlumbrecht MP, Penedo FJ, Pinheiro PS. Medina HN, et al. Among authors: schlumbrecht mp. Cancer Med. 2022 Mar;11(6):1490-1501. doi: 10.1002/cam4.4554. Epub 2022 Jan 30. Cancer Med. 2022. PMID: 35098701 Free PMC article.
88 results